Read Full Study Here
Aspirin, Xarelto show no difference in preventing venous thromboembolism after TJA.
Among patients who received 5 days of rivaroxaban prophylaxis after total hip or total knee arthroplasty, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism.
After patients received once-daily oral Xarelto (rivaroxaban, Bayer Pharma) until postoperative day 5, Michael Dunbar, MD, FRCSC, PhD, and colleagues then randomly assigned 3,424 patients … Read the rest